We are live on ! Find out more
Royal Bank of Canada

Royal Bank of Canada Portfolio holdings

AUM $570B
1-Year Est. Return 27.57%
 

Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.

This Fund
S&P 500
This Quarter Est. Return
+4.82%
1 Year Est. Return
+27.57%
3 Year Est. Return
+75.99%
5 Year Est. Return
+94.97%
10 Year Est. Return
+325.25%
AUM
$228B
AUM Growth
+$19.5B
Cap. Flow
+$9.66B
Cap. Flow %
4.24%
Top 10 Hldgs %
19.68%
Holding
7,447
New
331
Increased
2,461
Reduced
3,156
Closed
486

Sector Composition

Rank Sector Weight
1 Financials 21.73%
2 Energy 8.89%
3 Industrials 8.57%
4 Technology 7.69%
5 Communication Services 7.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCIJ
5551
DELISTED
Global X Scientific Beta Japan ETF
SCIJ
$19K ﹤0.01%
+600
New +$19.1K
PSDO
5552
DELISTED
Presidio, Inc. Common Stock
PSDO
$19K ﹤0.01%
1,015
-2,403
-70% -$37.8K
HLTH
5553
DELISTED
Nobilis Health Corp.
HLTH
$19K ﹤0.01%
14,510
-6,000
-29% -$8.28K
LOXO
5554
DELISTED
Loxo Oncology, Inc
LOXO
$19K ﹤0.01%
226
-44,455
-99% -$3.71M
FMI
5555
DELISTED
Foundation Medicine, Inc.
FMI
$19K ﹤0.01%
280
-1,239
-82% -$64.3K
CDOR
5556
DELISTED
Condor Hospitality Trust, Inc. Common Stock
CDOR
$19K ﹤0.01%
1,951
+1,932
+10,168% +$19.5K
ASYS icon
5557
Amtech Systems
ASYS
$280M
$18K ﹤0.01%
1,739
-6,678
-79% -$81.6K
BCLI
5558
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$18K ﹤0.01%
302
-1
-0.3% -$60
HERZ
5559
Herzfeld Credit Income Fund
HERZ
$32.4M
$18K ﹤0.01%
325
+139
+75% +$7.64K
EXK
5560
Endeavour Silver
EXK
$3.05B
$18K ﹤0.01%
7,628
-135,964
-95% -$307K
INO icon
5561
Inovio Pharmaceuticals
INO
$93M
$18K ﹤0.01%
364
-727
-67% -$45.1K
NWFL icon
5562
Norwood Financial Corp
NWFL
$376M
$18K ﹤0.01%
532
-413
-44% -$12.5K
QNST icon
5563
QuinStreet
QNST
$1.19B
$18K ﹤0.01%
2,167
-3,005
-58% -$25.5K
WVE icon
5564
Wave Life Sciences
WVE
$1.02B
$18K ﹤0.01%
500
-943
-65% -$27.5K
FFNW
5565
DELISTED
First Financial Northwest, Inc
FFNW
$18K ﹤0.01%
1,108
-551
-33% -$9.16K
DTEA
5566
DELISTED
DAVIDsTEA Inc. Common Stock
DTEA
$18K ﹤0.01%
4,705
ACH
5567
DELISTED
Alum Corp of China Ltd
ACH
$18K ﹤0.01%
1,000
LGCY
5568
DELISTED
Legacy Reserves Inc. Common Stock
LGCY
$18K ﹤0.01%
11,208
-2,465
-18% -$3.67K
ENY
5569
DELISTED
Invesco Canadian Energy Income ETF
ENY
$18K ﹤0.01%
2,186
CXRX
5570
DELISTED
Concordia International Corp. Common Stock
CXRX
$18K ﹤0.01%
27,475
-386,250
-93% -$266K
JO
5571
DELISTED
iPath Bloomberg Coffee Subindex Total Return ETN due June 24, 2038
JO
$18K ﹤0.01%
1,130
-250,587
-100% -$4M
CYTR
5572
DELISTED
CytRx Corp
CYTR
$18K ﹤0.01%
10,409
+840
+9% +$1.74K
KIQ
5573
DELISTED
Kelso Technologies Inc.
KIQ
$18K ﹤0.01%
34,000
-9,824
-22% -$3.96K
BBOX
5574
DELISTED
Black Box Corp
BBOX
$18K ﹤0.01%
5,200
OREX
5575
DELISTED
Orexigen Therapeutics, Inc.
OREX
$18K ﹤0.01%
13,851
+11,667
+534% +$19K

Similar funds

Royal Bank of Canada's Q4 2017 Portfolio in Review

As of Q4 2017, Royal Bank of Canada held 7,447 positions worth $228B, up 9.4% from $208B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Royal Bank of Canada deployed $9.66B of net new capital in Q4 2017, opening 331 new positions and adding to 2,461 existing holdings. Its largest new stake was Maxar Technologies Inc. Common Stock: 2,562,561 shares worth $165M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 22% a quarter earlier, followed by Energy and Industrials.

On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $611M trimmed.

  • Royal Bank of Canada's largest Q4 2017 buy was Maxar Technologies Inc. Common Stock: 2,562,561 shares worth $165M.
  • Royal Bank of Canada added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $2.31B increase.
  • Royal Bank of Canada's biggest Q4 2017 reduction was iShares Core S&P 500 ETF, cutting an estimated $611M.
  • Royal Bank of Canada fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $144M.
  • Royal Bank of Canada's ten largest holdings make up 20% of its $228B portfolio in Q4 2017.
  • Royal Bank of Canada opened 331 new positions and closed 486 in Q4 2017.
  • Royal Bank of Canada's portfolio value rose 9.4% quarter-over-quarter to $228B.

Based on Royal Bank of Canada's 13F filing for Q4 2017, filed 14 Feb 2018.